Isabel Puntmann
Overview
Explore the profile of Isabel Puntmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Troseid M, Arribas J, Assoumou L, Holten A, Poissy J, Terzic V, et al.
Crit Care
. 2023 Jan;
27(1):9.
PMID: 36627655
Background: Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. Methods: Bari-SolidAct is a phase-3, multicentre, randomised,...
2.
Moja L, Lucenteforte E, Kwag K, Bertele V, Campomori A, Chakravarthy U, et al.
Cochrane Database Syst Rev
. 2014 Sep;
(9):CD011230.
PMID: 25220133
Background: Neovascular age-related macular degeneration (AMD) is the leading cause of legal blindness in elderly populations of industrialised countries. Bevacizumab (Avastin®) and ranibizumab (Lucentis®) are targeted biological drugs (a monoclonal...
3.
Puntmann I, Schmacke N, Melander A, Lindberg G, Muhlbauer B
BMC Clin Pharmacol
. 2010 Mar;
10:5.
PMID: 20233429
Background: New drugs are generally claimed to represent a therapeutic innovation. However, scientific evidence of a substantial clinical advantage is often lacking. This may be the result of using inadequate...
4.
Ahrens W, Hagemeier C, Muhlbauer B, Pigeot I, Puntmann I, Reineke A, et al.
Pharmacoepidemiol Drug Saf
. 2007 Oct;
16(12):1298-307.
PMID: 17957709
Purpose: A less favourable galenic profile of generic formulations of the beta-blocker metoprolol raised the concern of a higher risk for serious cardiovascular (CV) events. We assessed hospital admission rates...
5.
Puntmann I, Wosniok W, Haeckel R
Clin Chem Lab Med
. 2003 Jul;
41(6):809-20.
PMID: 12880146
The applicability of point-of-care testing (POCT) glucometers for monitoring blood glucose concentrations has been demonstrated. However, their use in diagnosing type 2 diabetes is still debated. Therefore, a new statistical...
6.
Haeckel R, Brinck U, Colic D, Janka H, Puntmann I, Schneider J, et al.
Clin Chem
. 2002 May;
48(6 Pt 1):936-9.
PMID: 12029012
No abstract available.